Updated. News articles, statements and commentary EXCEL and NOBLE trials

---

06 January 2020

EXCEL Trial

SCTS Statement

Official Response

Joint Society Statement

BCIS Statement 

David Taggart Response

1.     EXCEL trial (8th December 2016)

https://www.nejm.org/doi/full/10.1056/NEJMoa1610227

2.     EXCEL trial 5-year outcomes (28th September 2019) 

https://www.nejm.org/doi/full/10.1056/NEJMoa1909406

https://solaci.org/_files/tct-2019/excel-5yearpdf.pdf

3.     TCTMD commentary (7th October 2019)

https://www.tctmd.com/news/former-excel-investigator-alleges-trial-manipulation-prompting-vehement-denials

4.     Medscape commentary (8th November 2019)

https://www.medscape.com/viewarticle/920997#vp_2

5.     BBC news story (9th December 2019)

https://www.bbc.co.uk/news/health-50715156

6.     EACTS initial response to Newsnight article (9th December 2019)

https://www.eacts.org/eacts-responds-to-bbc-newsnights-investigation-on-the-excel-trial/

7.     Cardiovascular news commentary (9th December 2019)

https://cardiovascularnews.com/eacts-issues-response-to-bbc-newsnight-investigation-of-excel-trial/

8.     TCTMD commentary (10th December 2019)

https://www.tctmd.com/news/eacts-pulls-out-left-main-guidelines-after-bbc-bombshell-alleging-excel-trial-cover

9.     British Cardiovascular Intervention Society (BCIS) statement (11th December 2019)

https://www.bcis.org.uk/wp-content/uploads/2019/12/The-Excel-controversy-finalab.pdf

10.  Society for Cardiothoracic Surgery in Great Britain & Ireland (SCTS) joint statement with BCS & BCIS (12th December 2019)

11.  Official response of EXCEL Leadership (12th December 2019)

https://www.tctmd.com/slide/official-response-excel-leadership

12.  Medscape commentary & podcast (13th December 2019)

https://www.medscape.com/viewarticle/922528

13.  SCTS second statement (18th December 2019)

14.  Taggart response to EXCEL rebuttal (19th December 2019)

https://www.tctmd.com/slide/response-david-taggart-md-phd-excel-statement

15.  EACTS subsequent statement (19th December 2019)

https://www.eacts.org/changing-evidence-changing-practice/

16.  ATTS statement (21st December 2019)

https://www.aats.org/aatsimis/AATSWeb/Association/About/Statement%20ESC-EACTS.aspx

17.  NOBLE trial (23rd December 2019)

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32972-1/fulltext

18.  TCTMD commentary on NOBLE trial (23rd December 2019)

https://www.tctmd.com/news/noble-5-years-new-data-favor-cabg-left-main-disease

19.  Medscape commentary on NOBLE trial (2nd January 2020)

https://www.medscape.com/viewarticle/923307

20. TCT commentary on CRF review (8th Jan 2020)

https://www.tctmd.com/news/eacts-offers-help-resolve-excel-controversy-crf-launches-review

21. STS Statement on Recent Left Main Randomized Trials (14th January 2020)

Lancet editorial regarding open access to research (25th January 2020).

22. Lancet editorial regarding open access to research (25th January 2020

23. BBC article of EXCEL trial (18th Feb 2020)

https://www.bbc.co.uk/news/health-51539112

24. EACTS Statement following 2nd Newsnight article

https://www.eacts.org/eacts-statement-bbc-newsnight-investigation/

25. Noninferiority Designed Cardiovascular Trials in Highest-Impact Journals (30th July 2019)

 

View other News